SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-007609
Filing Date
2017-01-11
Accepted
2017-01-11 11:52:02
Documents
1
Group Members
SBI INCUBATION CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 14 d326270dsc13da.htm SC 13D/A 51902
  Complete submission text file 0001193125-17-007609.txt   53745
Mailing Address 4-20-3 EBISU SHIBUYA-KU TOKYO M0 150-0013
Business Address 4-20-3 EBISU SHIBUYA-KU TOKYO M0 150-0013 81 3 5789-5872
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD (Subject) CIK: 0001400482 (see all company filings)

IRS No.: 981295657 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88011 | Film No.: 17522405
SIC: 2834 Pharmaceutical Preparations

Mailing Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019
Business Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019 81-3-6229-0122
SBI Holdings, Inc. (Filed by) CIK: 0001446698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13D/A